Molina Healthcare Earns Hold Consensus Rating from 13 Analysts, COO Buys Shares

Summary

Molina Healthcare, Inc (NYSE:MOH) has received a consensus rating of ‘Hold’ from thirteen analysts. Ten analysts rated it as a hold and three as a buy. The average one-year price target is $242.91. Recent price target cuts include Wells Fargo from $216 to $198, Barclays from $270 to $186, and JPMorgan from $272 to $184. COO James Woys purchased 10,000 shares at $155.94, increasing his ownership by 15.54%. Institutional investors own 98.50% of the stock, which opened at $180.87 with a market cap of $9.80 billion.Market Beat

Impact Analysis

So basically, Molina Healthcare is facing a mixed bag of analyst ratings, with a consensus ‘Hold’ and significant price target cuts from major firms like Wells Fargo, Barclays, and JPMorgan. The stock opened at $180.87, well below the average one-year price target of $242.91, indicating a cautious outlook from the market. However, the interesting part isn’t the analyst ratings—it’s the COO James Woys buying 10,000 shares at $155.94, boosting his ownership by 15.54%. This move suggests strong insider confidence in the company’s long-term prospects, despite the recent downgrades. Institutional ownership is also high at 98.50%, which could provide some stability. The market might be missing the potential upside here, especially if the insider purchase signals upcoming positive developments. I’d read this as a potential buying opportunity, particularly if the stock dips further and aligns closer to the insider purchase price.Market Beat